Literature DB >> 32212040

Plasma Ceramides in Relation to Coronary Plaque Characterization Determined by Optical Coherence Tomography.

Weili Pan1,2, Hui Dong1,2, Rong Sun1,2, Linlin Zhao1, Meng Sun1,2, Longyan Li3, Xianghao Yu1,2, Jinxin Liu1,2, Jianjun Wu1,2, Fan Yang1,2, Bo Yu4,5.   

Abstract

Plasma ceramides (Cer), a subset of bioactive lipids, have mechanistic links to development of atherosclerosis and are related to major adverse cardiovascular events (MACEs). Previous researches have demonstrated vulnerable plaques contribute to acute cardiovascular events and poor prognosis. This study aimed to explore the associations between Cer and culprit plaque characterizations evaluated by optical coherence tomography (OCT). It was found that plasma Cer are associated with culprit plaque vulnerability evaluated by OCT, providing evidence supporting proatherogenic roles and potential to act as markers for plaque vulnerability of Cer. Graphical Abstract With increasing plasma ceramide levels, the prevalence of thin-cap fibroatheroma (TCFA) and plaque rupture (PR) is higher, that is, culprit plaques are more vulnerable.

Entities:  

Keywords:  Plaque vulnerability; Plasma ceramides; RRLC-Q-TOF/MS; STEMI

Mesh:

Substances:

Year:  2020        PMID: 32212040     DOI: 10.1007/s12265-020-09978-3

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  28 in total

1.  Metabolomic profile for the early detection of coronary artery disease by using UPLC-QTOF/MS.

Authors:  Xiaobao Xu; Beibei Gao; Qijie Guan; Dandan Zhang; Xianhua Ye; Liang Zhou; Guoxin Tong; Hong Li; Lin Zhang; Jingkui Tian; Jinyu Huang
Journal:  J Pharm Biomed Anal       Date:  2016-06-25       Impact factor: 3.935

2.  nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe-/- Mice.

Authors:  Tom Lallemand; Myriam Rouahi; Audrey Swiader; Marie-Hélène Grazide; Nancy Geoffre; Paul Alayrac; Emeline Recazens; Agnès Coste; Robert Salvayre; Anne Nègre-Salvayre; Nathalie Augé
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-05-24       Impact factor: 8.311

3.  Sphingolipids Contribute to Human Atherosclerotic Plaque Inflammation.

Authors:  Andreas Edsfeldt; Pontus Dunér; Marcus Ståhlman; Ines G Mollet; Giuseppe Asciutto; Helena Grufman; Mihaela Nitulescu; Ana Flor Persson; Rachel M Fisher; Olle Melander; Marju Orho-Melander; Jan Borén; Jan Nilsson; Isabel Gonçalves
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-04-07       Impact factor: 8.311

Review 4.  Sphingolipid mediators in cardiovascular cell biology and pathology.

Authors:  T Levade; N Augé; R J Veldman; O Cuvillier; A Nègre-Salvayre; R Salvayre
Journal:  Circ Res       Date:  2001-11-23       Impact factor: 17.367

Review 5.  Intracoronary Optical Coherence Tomography 2018: Current Status and Future Directions.

Authors:  Ziad A Ali; Keyvan Karimi Galougahi; Akiko Maehara; Richard A Shlofmitz; Ori Ben-Yehuda; Gary S Mintz; Gregg W Stone
Journal:  JACC Cardiovasc Interv       Date:  2017-12-26       Impact factor: 11.195

Review 6.  Advances in determining signaling mechanisms of ceramide and role in disease.

Authors:  Jeffrey L Stith; Fabiola N Velazquez; Lina M Obeid
Journal:  J Lipid Res       Date:  2019-03-07       Impact factor: 5.922

7.  Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial (Prevención con Dieta Mediterránea).

Authors:  Dong D Wang; Estefanía Toledo; Adela Hruby; Bernard A Rosner; Walter C Willett; Qi Sun; Cristina Razquin; Yan Zheng; Miguel Ruiz-Canela; Marta Guasch-Ferré; Dolores Corella; Enrique Gómez-Gracia; Miquel Fiol; Ramón Estruch; Emilio Ros; José Lapetra; Montserrat Fito; Fernando Aros; Luis Serra-Majem; Chih-Hao Lee; Clary B Clish; Liming Liang; Jordi Salas-Salvadó; Miguel A Martínez-González; Frank B Hu
Journal:  Circulation       Date:  2017-03-09       Impact factor: 29.690

8.  Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice.

Authors:  Tae-Sik Park; Wendy Rosebury; Erick K Kindt; Mark C Kowala; Robert L Panek
Journal:  Pharmacol Res       Date:  2008-06-20       Impact factor: 7.658

9.  Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.

Authors:  Reijo Laaksonen; Kim Ekroos; Marko Sysi-Aho; Mika Hilvo; Terhi Vihervaara; Dimple Kauhanen; Matti Suoniemi; Reini Hurme; Winfried März; Hubert Scharnagl; Tatjana Stojakovic; Efthymia Vlachopoulou; Marja-Liisa Lokki; Markku S Nieminen; Roland Klingenberg; Christian M Matter; Thorsten Hornemann; Peter Jüni; Nicolas Rodondi; Lorenz Räber; Stephan Windecker; Baris Gencer; Eva Ringdal Pedersen; Grethe S Tell; Ottar Nygård; Francois Mach; Juha Sinisalo; Thomas F Lüscher
Journal:  Eur Heart J       Date:  2016-04-28       Impact factor: 29.983

10.  Co-localization of plaque macrophages with calcification is associated with a more vulnerable plaque phenotype and a greater calcification burden in coronary target segments as determined by OCT.

Authors:  Mathias Burgmaier; Andrea Milzi; Rosalia Dettori; Kathrin Burgmaier; Nikolaus Marx; Sebastian Reith
Journal:  PLoS One       Date:  2018-10-24       Impact factor: 3.240

View more
  8 in total

1.  Letter to the Editor.

Authors:  Grace Brown; Juhi Rastogi; Mahmood Ahmad
Journal:  J Cardiovasc Transl Res       Date:  2021-06-03       Impact factor: 4.132

Review 2.  Ceramides and Ceramide Scores: Clinical Applications for Cardiometabolic Risk Stratification.

Authors:  Mika Hilvo; Vlad C Vasile; Leslie J Donato; Reini Hurme; Reijo Laaksonen
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-29       Impact factor: 5.555

3.  Serum Ceramides as Prognostic Biomarkers of Large Thrombus Burden in Patients with STEMI: A Micro-Computed Tomography Study.

Authors:  Efstratios Karagiannidis; Andreas S Papazoglou; Nikolaos Stalikas; Olga Deda; Eleftherios Panteris; Olga Begou; Georgios Sofidis; Dimitrios V Moysidis; Anastasios Kartas; Evangelia Chatzinikolaou; Kleoniki Keklikoglou; Andreana Bompoti; Helen Gika; Georgios Theodoridis; Georgios Sianos
Journal:  J Pers Med       Date:  2021-01-31

4.  Ceramides and Cardiovascular Risk Factors, Inflammatory Parameters and Left Ventricular Function in AMI Patients.

Authors:  Elena Michelucci; Silvia Rocchiccioli; Melania Gaggini; Rudina Ndreu; Sergio Berti; Cristina Vassalle
Journal:  Biomedicines       Date:  2022-02-11

Review 5.  Ceramides as Mediators of Oxidative Stress and Inflammation in Cardiometabolic Disease.

Authors:  Melania Gaggini; Rudina Ndreu; Elena Michelucci; Silvia Rocchiccioli; Cristina Vassalle
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

6.  Ceramides and phospholipids in plasma extracellular vesicles are associated with high risk of major cardiovascular events after carotid endarterectomy.

Authors:  Nathalie Timmerman; Farahnaz Waissi; Dominique P V de Kleijn; Reijo Laaksonen; Mirthe Dekker; Gert J de Borst; Joelle van Bennekom; Robbert J de Winter; Mika Hilvo; Antti Jylhä; Gerard Pasterkamp
Journal:  Sci Rep       Date:  2022-04-01       Impact factor: 4.379

Review 7.  Plasma Ceramides in Cardiovascular Disease Risk Stratification.

Authors:  Débora L M Junqueira; Alline Stach; Adriano Caixeta; Juliana Sallum; Erika Yasaki; Jeane Tsutsui; Edgar Rizatti; Carlos E Rochitte; Jean-Paul Kovalik; José E Krieger; A Mark Richards; Mark Y Chan; Leonardo P de Carvalho
Journal:  Arq Bras Cardiol       Date:  2022-04       Impact factor: 2.000

Review 8.  Sphingolipid metabolism and signaling in cardiovascular diseases.

Authors:  Sonia Borodzicz-Jażdżyk; Piotr Jażdżyk; Wojciech Łysik; Agnieszka Cudnoch-Jȩdrzejewska; Katarzyna Czarzasta
Journal:  Front Cardiovasc Med       Date:  2022-08-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.